0
CABS Symposium: CAR-T and Cell Therapy
会议时间:
2019年04月06日-2019年04月06日
主办单位:
CABS
主题介绍:
Do you like to be informed of the latest research and development on T cell gene editing and engineering technology? Are you aware of the assay options to detect CAR expression? Do you have any interest in the PK/PD of CAR-T therapy? If the answer is “yes”, you are very welcome to join us in a symposium on CAR-T and Cell Therapy that will be held on April 6, 2019 by CABS Science & Technology Committee. You will also have opportunities to network with some of the industry professionals of T cell immunotherapy.
会议日程:
1:00 to 1:20 PM Check-in and networking.
1:20 to 1:30 PM Welcome remarks from CABS.
1:30 to 2:15PM Gene editing in T-cell therapy. Ling-Jie Kong, PhD, Vice President, Technology Development, Applied StemCell, Inc.
2:15 to 3:00 PM An Ideal Solution for the Detection of CAR Expression. Jane Liu, Product Manager, ACROBiosystems
3:00 to 3:15 PM Break
3:15 to 4:00 PM Pharmacokinetic/Pharmacodynamic Aspects of Developing CAR-T Therapies. James Kalabus, PhD, Principal Scientist, Clinical Pharmacology, Modeling & Simulation, Amgen.
4:00 to 4:45 PM A Novel T-cell Engineering Technology (ARTEMISTM) with Favorable Efficacy/Safety Profile in Solid and Hematologic Cancers.Jingyi Xiang, PhD, Director of Scientific Alliances, Eureka Therapeutics, Inc.
4:45 to 5:30 PM Allogeneic CAR T for Cancer Treatment. Barbra Sasu, PhD, Chief Scientific Officer, Allogene.
5:30 to 6:00 PM Refreshment & Networking.
推荐会议更多
ACRO最新 & 热门产品
补充会议信息
赢取积分奖励
赢取积分奖励
申请免费参会名额
兑换成功!
免费名额将于3个工作日内发送至您的注册手机和邮箱,
请注意查收~
申请成功!
您已成功申请此次会议资料包,
我们将于2个工作日内将资料包发送至您的邮箱,请注意查收
申请会议资料包
转发分享下面链接后截图上传,即可或得对应会议资料。